The role of ocular surface inflammation in post-surgical patient dissatisfaction

February 23, 2026

Post-surgical dissatisfaction remains a significant challenge in modern ophthalmology, even when surgical procedures are technically successful. Patients may report persistent discomfort, fluctuating vision, or unmet visual expectations despite optimal surgical outcomes.

Increasing evidence suggests that ocular surface inflammation plays a central, yet often underestimated, role in these cases. Subclinical inflammatory changes can significantly affect postoperative comfort and visual quality, shaping the patient’s perception of surgical success.

Understanding ocular surface inflammation

Ocular surface inflammation refers to a spectrum of inflammatory responses affecting the tear film, eyelids, conjunctiva, and corneal surface.

Unlike acute inflammatory conditions, low-grade ocular surface inflammation may not produce obvious clinical signs. However, it can alter tear film stability, epithelial integrity, and neurosensory function, all of which directly influence visual performance and comfort.

In many surgical candidates, this inflammatory state is already present before surgery but remains undetected.

Why surgical success does not always equal patient satisfaction

From a clinical standpoint, surgery may be considered successful based on anatomical correction and visual acuity measurements. From the patient’s perspective, however, success is closely linked to daily visual experience and ocular comfort.

Ocular surface inflammation can lead to:

• Fluctuating vision throughout the day
• Foreign body sensation or burning
• Light sensitivity
• Delayed visual recovery

These symptoms may persist postoperatively and negatively impact patient satisfaction, even when objective surgical metrics are optimal.

The impact of inflammation on postoperative visual quality

Inflammation alters tear film composition and stability, increasing tear evaporation and surface irregularity. This results in unstable optical quality at the corneal surface, which is critical for high-quality vision.

Patients may describe:

• Intermittent blur
• Reduced contrast sensitivity
• Variable visual clarity depending on environmental conditions

Such issues are particularly relevant after refractive or cataract surgery, where expectations for visual performance are high.

Subclinical inflammation: the hidden risk factor

One of the main challenges is that ocular surface inflammation is often subclinical.

Patients may:

• Report minimal or no symptoms preoperatively
• Show normal findings on traditional dry eye tests
• Develop noticeable symptoms only after surgery

Surgical stress, postoperative medications, and environmental exposure can exacerbate pre-existing inflammatory conditions, transforming a silent issue into a symptomatic postoperative problem.

Postoperative medications and inflammatory load

Topical postoperative treatments, while essential, can contribute to ocular surface inflammation. Preservatives, frequent instillation schedules and prolonged use of certain medications may disrupt the tear film and epithelial surface. In patients with pre-existing inflammatory vulnerability, this additional load may prolong recovery and worsen postoperative comfort.

Understanding this interaction is essential when evaluating postoperative dissatisfaction.

Clinical implications for pre- and post-surgical evaluation

Recognizing ocular surface inflammation as a determinant of patient satisfaction has important clinical implications.

A comprehensive approach should include:

• Preoperative identification of inflammatory risk factors
• Objective tear film and surface assessment
• Postoperative monitoring focused on comfort and visual stability, not only visual acuity

Addressing inflammation before surgery can improve measurement reliability and reduce the risk of postoperative dissatisfaction.

Why objective ocular surface assessment matters

Because inflammation-related tear film instability can fluctuate, objective and repeatable assessment methods are essential.

Non-invasive evaluation allows clinicians to:

• Detect subtle tear film alterations
• Monitor inflammatory trends over time
• Adjust management strategies proactively

This approach supports more accurate clinical decisions and aligns surgical success with patient-perceived outcomes.

Ocular surface inflammation is a key contributor to postoperative dissatisfaction, even when surgery is technically successful.

By influencing tear film stability, visual quality, and comfort, subclinical inflammation shapes the patient’s postoperative experience. Recognizing and managing this factor before and after surgery enables clinicians to bridge the gap between surgical excellence and patient satisfaction.

In modern ophthalmic practice, managing inflammation is no longer optional, it is essential for achieving outcomes that truly meet patient expectations.